Here is Part 2 of our two-part series on Clinical Trials from the Patient Perspective.  This time we hear from the experts who have solutions to the issues raised in Part 1.  We continue to explore how research processes were impacted by Covid 19 and the race to find vaccines and treatments.  Spoiler Alert – there are some Covid silver linings for those of us looking for change in MBC research.  Co-hosts Jim Kremens, Lisa Laudico, and Sarah Mann, speak with experts Susan Colen of BreastCancerTrials.org, Deb Collyar of PAIR, Dr. Neal Fischbach of Yale New Haven Health, bioethicist Jill Manning of Mass General Brigham, Dr. Corrie Painter of Count Me In and the Broad Institute, Kristin Schneeman of Faster Cures and the Milken Institute along with MBC Patient Advocates, Christine Hodgdon of GRASP & Stormriders.org and Lianne Kraemer. Want more information, please check out our extensive episode notes for this episode including an infographic that describes the clinical trial search landscape for individuals living with MBC. Look for a full episode on April 5 covering our interview with Judy Perkins.  More info available on our website www.ourmbclife.orgGot something to Share? Feedback? Email:  ourmbclife@sharecancersupport.org  Send us a voice recording via email or through speakpipe on our website. Follow on Facebook, Instagram, and Twitter @ourmbclife